Stock & Company Details
Travere Therapeutics Inc $TVTX
Price:
N/A
N/A
94M
$6.4B
52 Week High:
N/A
10 Day Average Volume:
N/A
-132.56
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
TVTX technical indicators
Latest Travere Therapeutics Inc (TVTX) indicator readings as of 2026-08-28.
TVTX's 14-day RSI is 61.8, in neutral territory. At $65.67 it is trading 57.7% above its 200-day moving average of $41.63, and above its 50-day average of $59.30. Price sits in the middle of its Bollinger Bands ($56.43 to $69.61). ADX reads 35.0, indicating a trending market.
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN) - rare kidney disorders that often cause end-stage kidney disease.
Finance Bot
Ask your questions
Start by typing a question below.
